Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis. Issue 47 (11th November 2016)

• Record Type: Journal Article
• Authors: Daniel, Catherine; Titecat, Marie; Poiret, Sabine; Cayet, Delphine; Boutillier, Denise; Simonet, Michel; Sirard, Jean-Claude; Lemaître, Nadine; Sebbane, Florent
• Is Part Of: Vaccine. Volume 34:Issue 47(2016)
• Page Start: 5762
• Page End: 5767
• Publication Date: 2016-11-11
• Subjects: Yersinia -- LcrV -- Vaccination -- Lactococcus lactis; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2016.09.060
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Background: Pseudotuberculosis is an infection caused by the bacterial enteropathogen Yersinia pseudotuberculosis and is considered to be a significant problem in veterinary medicine. We previously found that intranasal administration of a recombinant Lactococcus lactis strain that secretes the low-calcium response V (LcrV) antigen from Y. pseudotuberculosis (Ll-LcrV) confers protection against a lethal Y. pseudotuberculosis infection. Here, we aimed at characterizing the immunological basis of this LcrV-elicited protective response and at determining the duration of vaccine-induced immunity. Methods: Splenocytes from BALB/c mice intranasally immunized with Ll-LcrV or Ll as control were immunostained then analyzed by flow cytometry. Protection against a lethal intravenous injection of Y. pseudotuberculosis was also determined (i) in immunized BALB/c mice depleted or not of CD4 +, CD8 + or CD25 + cells and (ii) in naïve BALB/c mice receiving serum from immunized mice by counting the number of bacteria in liver and spleen. Lastly, survival rate of immunized BALB/c mice following a lethal intravenous injection of Y. pseudotuberculosis was followed up to 9-months. Results: We found that T and B lymphocytes but not non-conventional lymphoid cells were affected by Ll-LcrV immunization. We also observed that depletion of CD4 + and CD25 + but not CD8 + cells in immunized mice eradicated protection against a lethal systemic Y. pseudotuberculosis infection, suggesting that activated CD4 + T lymphocytes are required for vaccine-induced protection. Adoptive transfer of LcrV-specific antibodies from Ll-LcrV-immunized animals significantly reduced the bacterial counts in the liver compared to non-vaccinated mice. Lastly, the protective immunity conferred by Ll-LcrV decreased slightly over time; nevertheless almost 60% of the mice survived a lethal bacterial challenge at 9 months post-vaccination. Conclusion: Mucosal vaccination of mice with Ll-LcrV induced cell- and antibody-mediated protective immunity against Y. pseudotuberculosis infection in the mouse and the protection is long-lasting.